Effects of extended-release memantine (28 mg, once daily) on language and communication abilities in patients with moderate to severe alzheimer's disease

Category Primary study
JournalConsultant Pharmacist
Year 2012
This article has no abstract
Epistemonikos ID: c63d6ca597df74009eeeba54dcae07460b8996ea
First added on: Feb 05, 2025